Australia markets closed

Benitec Biopharma Inc. (BNTC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.1301+0.3001 (+10.60%)
At close: 03:48PM EST
3.0400 -0.09 (-2.88%)
After hours: 04:40PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 8.05M
Enterprise value -17.32M
Trailing P/E 51.55
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)19.25
Price/book (mrq)0.36
Enterprise value/revenue -230.95
Enterprise value/EBITDA 0.86

Trading information

Stock price history

Beta (5Y monthly) 0.92
52-week change 3-3.21%
S&P500 52-week change 315.23%
52-week high 39.0100
52-week low 31.8600
50-day moving average 33.3424
200-day moving average 33.5614

Share statistics

Avg vol (3-month) 315.09k
Avg vol (10-day) 315.07k
Shares outstanding 52.57M
Implied shares outstanding 62.57M
Float 82M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short (14 Nov 2023) 433.42k
Short ratio (14 Nov 2023) 43.33
Short % of float (14 Nov 2023) 41.75%
Short % of shares outstanding (14 Nov 2023) 41.30%
Shares short (prior month 12 Oct 2023) 458.6k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 317 Nov 2019
Ex-dividend date 4N/A
Last split factor 21:17
Last split date 325 July 2023

Financial highlights

Fiscal year

Fiscal year ends 29 June 2023
Most-recent quarter (mrq)29 Sept 2023


Profit margin 0.00%
Operating margin (ttm)-27,166.67%

Management effectiveness

Return on assets (ttm)-56.39%
Return on equity (ttm)-110.63%

Income statement

Revenue (ttm)75k
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)75k
EBITDA -20.26M
Net income avi to common (ttm)-20.42M
Diluted EPS (ttm)-234.8200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)25.86M
Total cash per share (mrq)10.05
Total debt (mrq)491k
Total debt/equity (mrq)2.20%
Current ratio (mrq)5.82
Book value per share (mrq)8.76

Cash flow statement

Operating cash flow (ttm)-18.54M
Levered free cash flow (ttm)-10.65M